5 Most Promising Healthcare Stocks According to Analysts

Page 5 of 5

1. Sanofi (NASDAQ:SNY)

Average Analyst Price Target Upside: 98.1%

Average Analyst Price Target: $96.16

Sanofi (NASDAQ:SNY) is a pharmaceutical and healthcare company that discovers, develops, manufactures, and markets a range of medicines and vaccines for conditions like cancer, multiple sclerosis, and more.

On December 7, Sanofi (NASDAQ:SNY) said that Sarclisa (isatuximab), a drug for multiple myeloma, met the primary endpoints of a late-stage trial. Dietmar Berger, the company’s global head of development, called the drug a “best-in-class medicine”.

On November 27, Sanofi (NASDAQ:SNY) announced that its drug, Dupixent (dupilumab), jointly developed with Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), yielded positive data from a second Phase 3 trial. The companies plan on submitting the data of trials for chronic obstructive pulmonary disease (COPD) to the U.S. FDA by the end of 2023.

Follow Sanofi Aventis (NYSE:SNY)

You can also look at the 12 High Growth IT Stocks to Buy and the 12 Best CBD Stocks To Buy Now.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5